Skip to main content
. 2004 Jun;48(6):2091–2096. doi: 10.1128/AAC.48.6.2091-2096.2004

FIG. 1.

FIG. 1.

Mean ± standard deviation atazanavir (A) and ritonavir (B) concentration-time profiles for patients who received atazanavir at 300 mg QD plus ritonavir at 100 mg QD in the absence (close symbols and solid lines) or the presence (open symbols and dotted lines) of tenofovir DF at 300 mg QD.